๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

โœ Scribed by Steven Bentivegna; Jianbiao Zheng; Eugeni Namsaraev; Victoria E.H. Carlton; Adam Pavlicek; Martin Moorhead; Farooq Siddiqui; Zhiyong Wang; Liana Lee; James S. Ireland; Kent Suyenaga; Thomas D. Willis; Malek Faham; Albert B. Seymour


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
367 KB
Volume
29
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Communicated by Richard Wooster

Mismatch repair detection (MRD) was used to screen 93 matched tumor-normal sample pairs and 22 cell lines for somatic mutations in 30 cancer relevant genes. Using a starting amount of only 150 ng of genomic DNA, we screened 102 kb of sequence for somatic mutations in colon and breast cancer. A total of 152 somatic mutations were discovered, encompassing previously reported mutations, such as BRAF V600E and KRAS G12S, G12V, and G13D, as well as novel mutations, including some in genes in which somatic mutations have not previously been reported, such as MAP2K1 and MAP2K2. The distribution of mutations ranged widely within and across tumor types. The functional significance of many of these mutations is not understood, with patterns of selection only evident in KRAS and BRAF in colon cancer. These results present a novel approach to high-throughput mutation screening using small amounts of starting material and reveal a mutation spectrum across 30 genes in a large cohort of breast and colorectal cancers.


๐Ÿ“œ SIMILAR VOLUMES


Novel TP53 gene mutations in tumors of R
โœ A. Lambrinakos; M. Yakubovskaya; J.J. Babon; A.A. Neschastnova; Ya.V. Vishnevska ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 281 KB ๐Ÿ‘ 2 views

## Communicated by Mark H. Paalman Mutations in the tumor-suppressor p53 gene TP53 are frequent in most human cancers including breast cancer. A new solid phase chemical cleavage of mismatch method (CCM) allowed rapid and efficient screening and analysis of the TP53 gene in DNA samples extracted